Table 4.
Postoperative complications after surgery and mortality within 30 days.
| Characteristics | Number of Neoadjuvant therapy cycles (%) | P value | |
|---|---|---|---|
| 2 (n=150) | 3-4 (n=101) | ||
| Postoperative complications | |||
| Yes | 42 (28.0) | 13 (12.9) | 0.004 |
| No | 108 (72.0) | 88 (87.1) | |
| Complication types | n=42 | n=13 | 0.192 |
| Pneumonia | 21 (50.0) | 5 (38.5) | 0.467 |
| Prolonged air leak | 8 (19.0) | 2 (15.4) | 1 |
| Arrhythmia/Cardiac failure | 4 (9.5) | 0 | 0.562 |
| Chyle | 1 (2.4) | 2 (15.4) | 0.136 |
| Gastrointestinal complications | 2 (4.8) | 1 (7.7) | 0.562 |
| Urinary retention | 0 | 2 (15.4) | 0.053 |
| Respiratory failure | 1 (2.4) | 0 | 1 |
| Hoarseness | 1 (2.4) | 0 | 1 |
| Hepatic dysfunction | 1 (2.4) | 1 (7.7) | 0.420 |
| Immunologic hepatitis | 2 (4.8) | 0 | 1 |
| Immunologic myocarditis | 1 (2.4) | 0 | 1 |
| 30-day mortality | |||
| No | 148 (98.7) | 101 (100.0) | 0.244 |
| Yes | 2 (1.3) | 0 | |